For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...

Cigna Group is launching a new rebate-free pharmacy benefit model which aims to bring down drug costs directly at the counter ...

The Cigna Group recorded $1.87 billion in profit in Q3, beating analysts’ expectations as shares ticked up prior to the ...

Cigna announced Monday morning that what it's calling a "new era" for its PBM unit is built on three core elements: ...

The Cigna Group CI reported third-quarter 2025 adjusted earnings per share (EPS) of $7.83, which beat the Zacks Consensus ...

Cigna Evernorth unveils rebate-free pharmacy model to lower drug costs and simplify pricing for fully insured members by 2027.

Cigna stock fell after Q3 results showed solid revenue but forecasted margin pressure in its pharmacy benefit services over ...

Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...

The Cigna Group is reaffirming its outlook for the year after posting $1.9 billion in profit for the third quarter. | The ...

The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it ...

The Cigna Group (NYSE:CI) is one of the most undervalued large cap stocks to buy right now. On October 28, Andrew Mok CFA ...

The Cigna Group reported third quarter net income of nearly $2 billion despite rising costs in the health plans it sells.